Original Ar ticle Singapore Med J 2010; 51(7) : 565
Novel electrogram device with web-
based service centre for ambulatory
ECG monitoring
Tan B Y, Ho K L, Ching C K, Teo W S
ABSTRACT yields. There is a trend toward a shorter
Introduction: Arrhythmias are often monitoring time for HW. The ability of HW
intermittent, and a normal electrocardiogram to record and transmit via the web, the earlier
(ECG) may not be diagnostic. The purpose review of data and low unreadable data make
of this study was to evaluate the usefulness HW an attractive alternative to TT.
of HeartWave500 (HW), a novel web-based
ambulatory ECG monitoring device. Keywords: arrhythmia detection,
HeartWave500, transtelephonic event
Methods: A total of 120 patients from the recorder, web-based monitoring
National Heart Centre, Singapore were Singapore Med J 2010; 51(7): 565-569
prospectively randomised in a three to one ratio
to either HW or a standard transtelephonic INTRODUCTION
(TT) event recorder. HW records five leads Cardiac arrhythmia is a potential cause of palpitations.
and transmits to an internet server, while Due to the paroxysmal nature of the symptoms,
TT transmits audio data to a central station. a conventional electrocardiogram (ECG) can be
Monitoring was conducted for two weeks. The generated in only a third of patients. The demand for
diagnostic yield was calculated in two ways: the an ambulatory form of electrographic monitoring was
percentage of patients successfully diagnosed as recognised as early as the 1940s, when Dr Norman
a function of time, and the absolute number of Jeff Holter developed a 34 kg backpack that could
new diagnoses per patient per week. simultaneously record and transmit ECGs. The modern
“Holter” monitor has shrunk dramatically and can record
Results: 33 patients (14 male, 19 female; mean up to 1–2 days of continuous data. The specificity of
age 49.6 +/− 11.1 years) were randomised to TT. the monitor is low however, with a reported diagnostic
87 patients (32 male, 55 female; mean age 43.7 yield of only 33%–35%.(1-3) A transtelephonic (TT)
National Heart
Centre, +/− 12.2 years) were randomised to HW. At the electrographic monitor is capable of recording
Mistri Wing, end of two weeks, the percentage of patients electrographic data and converting it to an audio signal.
17 Third Hospital
Avenue, diagnosed with any arrhythmia was similar for These signals are then transmitted by telephone to a
Singapore 168752
both groups (66.7 percent for TT versus 67.8 central station. A TT device can monitor patients for a
Tan BY, MBChB, percent for HW). There was a trend toward longer time, and the recordings have better correlations
MRCP, FAMS
Consultant significance for the number of diagnoses per with patient symptoms. The reported diagnostic yield
Ho KL, MBBS, patient per week for Week 2 between TT and for TT is 55%–83%.(2-4)
MRCP
HW (0.58 +/− 0.75 versus 0.34 +/− 0.55, p is With the rapid development of telemedicine
Consultant
0.06). Transmitted ECGs were read earlier worldwide, a web-based ambulatory monitoring device
Ching CK, MBBS,
MRCP for HW (18 minutes vs. 1107 minutes, Mann- would be the next logical step. The aim of our study
Consultant
Whitney non-parametric test, p is less than was to explore the usefulness of HeartWave500 (HW)
Teo WS, MRCP, FACC, 0.05). Transmitted recordings that were (NextWave Biomedical, Singapore), a novel internet-
FAMS
Senior Consultant unreadable were also significantly lower for based ambulatory ECG monitoring device. The HW
Correspondence to: HW (8.0 percent vs. 17.6 percent, chi-square (Fig. 1) was developed as a replacement for our current
Dr Tan Boon Yew
test, p is less than 0.05). TT event recorders. It is no larger than a personal digital
Tel: (65) 9223 6386
Fax: (65) 6223 0972 assistant, runs on AA batteries, and records using five
Email: drboonyewtan@
msn.com Conclusion: HW and TT have similar diagnostic leads. It is an event recorder that can record up to
Singapore Med J 2010; 51(7) : 566
cardiac rhythms (normal sinus rhythm, sinus
arrhythmia, sinus tachycardia [heart rate > 100/
min], premature ventricular contractions, low atrial
rhythm, wandering atrial pacemaker, occasional
atrial premature beats and normal paced rhythm), or
clinically significant cardiac rhythms (ventricular
tachycardia, sinus bradycardia [< 50/min], complete or
high-grade heart block, ventricular flutter/fibrillation,
supraventricular tachycardia [SVT], atrial flutter,
atrial fibrillation [AF] and junctional tachycardia). For
the HW device, a computer-generated diagnosis was
Fig.1 HeartWave500 device
also available. These include normal sinus rhythm,
sinus arrhythmia, sinus tachycardia, premature
three events at any one time. The recorded ECGs are ventricular contractions, ventricular tachycardia, sinus
downloaded onto a computer with the use of a standard bradycardia, second-degree heart block and ventricular
universal serial bus port. The images are then emailed flutter/fibrillation.
as an attachment to a central mainframe computer. A For the purpose of this study, initial transmission
computer-generated provisional diagnosis is available of a particular rhythm was considered as a diagnostic
immediately. Should an abnormal rhythm be detected, a event, while further transmission of the same rhythm
telephone short message service (SMS) is forwarded to was not considered as a new diagnosis. Transmissions
a technician or physician. Patient information, baseline of a different arrhythmia were considered to represent
ECGs and the transmitted recordings can be accessed additional diagnoses. The diagnostic yield for both
via the secure website. Symptoms can be reported and the TT and HW devices were calculated in two ways:
medical advice can be dispensed online, thus providing the percentage of patients successfully diagnosed as
reassurance to patients. a function of time; and the absolute number of new
diagnoses per patient per week. For the first outcome,
METHODS the cumulative percentage of patients with one, two or
Patients were randomly assigned in a 3:1 ratio to either three diagnoses as a function of time was calculated.
HW or a standard TT event recorder (RhythmCard, For the second outcome, the absolute number of new
Intromedix Inc Central station: Cardiocomm GEMS diagnoses made in a given week was divided by the
II, CardioComm Solutions Inc, Victoria, BC, Canada). number of patients who continue to wear either the TT
Informed written consent was obtained, and all the or HW device.
patients were counselled on the proper use of either The data was analysed using the Stata program
the TT or HW device by our trained staff. One trial (Stata, College Station, TX, USA). A comparison
transmission was performed in the hospital under between the continuous variables was performed
supervision in order to ensure proficiency with using the Student’s t-test or the Mann-Whitney non-
handling the devices. Helplines were made available parametric test. For categorical variables, a comparison
to all patients throughout the two-week duration of was made using the Pearson chi-square test. The
monitoring. The patients were encouraged to maintain cumulative percentage of patients with any diagnosis
a diary of symptoms. Baseline characteristics for age, as a function of time was estimated using the Kaplan-
gender, race and drug therapy were recorded. History Meier technique. For the second outcome (number
of hypertension, diabetes mellitus, hyperlipidaemia of diagnoses/patient/week), a comparison was made
and smoking were noted. Symptoms of palpitations between the two devices using the Student’s t-test.
were defined as any feelings of abnormal heartbeat
or rhythm experienced by the patient. Presyncope RESULTS
was defined as having symptoms of light-headedness The baseline characteristics of both the TT and HW
or dizziness, while syncope was the complete loss of groups of patients are shown in Table I. 33 patients were
consciousness. The durations of all the three symptoms randomised to the TT group. Their mean age was 49.6
were documented (< 1 min, 1–5 min, 6–120 min or > ± 11.1 (range 23–73) years, with 14 (42%) male and 19
120 min). (58%) female. All 33 patients had palpitations (seven
The diagnoses were divided into either benign [21%] patients < 1 min, 12 [36%] patients 1–5 min, nine
Singapore Med J 2010; 51(7) : 567
Table I. Baseline characteristics.
and one was known to have arrhythmogenic right
Characteristic No. (%) ventricular cardiomyopathy. One patient had a history
Transtelephonic HeartWave500 of non-sustained ventricular tachycardia. Three patients
(n = 33) (n = 87)
had previous permanent pacemaker implantation,
and one patient had a ventricular septal defect repair
Gender
Male 14 (42%) 32 (37%) procedure performed as a child. Two patients were on
Female 19 (58%) 55 (63%) only Vaughan Williams class I drugs, flecainide (iNova
Race
Pharmaceuticals Pty Ltd, Thornleigh, NSW, Australia)
Chinese 27 (82%) 70 (80%)
Malay 1 (3%) 5 (7%) and propafenone (Abbott Laboratories, Abbott Park,
Indian 3 (9%) 9 (10%) IL, USA), seven patients were on class II drugs alone
Others 2 (6%) 3 (3%)
(four on atenolol, three on propanolol) while two
Symptoms
Palpitations 33 (100%) 83 (95%) patients were on both flecainide and bisoprolol [Merck
Presyncope 10 (30%) 24 (24%) Serono, Geneva, Switzerland]. Four patients were on
Syncope 2 (6%) 3 (3%)
Class III drugs (two on sotalol [Pharmaforte Pte Ltd,
Anti-arrhythmic drugs 5 (15%) 15 (17%)
Hypertension 1 (3%) 12 (14%) Singapore], and two on amiodarone [Sanofi-Avents,
Smoking 5 (15%) 5 (6%) Paris, France]). There was no statistically significant
Hyperlipidaemia 9 (27%) 10 (11%)
difference in the baseline characteristics for age, gender,
Diabetes mellitus 1 (3%) 3 (3%)
race, symptoms and duration at presentation, as well as
history of hypertension, diabetes mellitus and smoking
status between the two groups.
[27%] patients 6 min–1 hr, five [15%] patients > 1 hr in For TT, a total of 108 transmissions were made
duration). Ten patients had presyncope (four patients < by 33 patients over the two weeks of monitoring. Of
1 min, three patients 1–5 min, two patients 6 min–1 hr these, 19 (18%) were unreadable. The median time
and one patient > 1 hr in duration). Two patients had from ECG transmission to being read by a technician
syncope. One patient had a previous history of non- was 1,107 (range 2–19,581) minutes. Normal sinus
sustained ventricular tachycardia and another had mitral rhythm was diagnosed in 16 patients, sinus arrhythmia
valve prolapse. Four patients were on anti-arrhythmic in 12, sinus tachycardia in eight, premature ventricular
drugs, two were on Vaughan Williams class II drugs, contractions in four, atrial premature beats in two, and
atenolol (Beacons Pharmaceuticals, Singapore) and sinus bradycardia, supraventricular tachycardia and
propanolol (Astra Zeneca UK Ltd, London, UK), one atrial fibrillation in one patient each. For HW, the 87
was on Vaughan Williams class IV drugs, diltiazem patients in this group had 609 attempts at recordings
(Beacons Pharmaceuticals, Singapore) and one on and a corresponding 609 attempted transmissions (from
Vaughan Williams class I drugs, disopyramide (Pfizer patient diaries). 493 (81%) attempts at recording were
Inc, New York, NY, USA) successful, and of these successful recordings, 445
87 patients were randomised to the HW group. (90%) were transmitted. However, the central station
Their mean age was 43.7 ± 12.2 (range 21–56) years, received only 424 transmissions; the remaining 21
with 32 (37%) male and 55 (63%) female. 83 (95%) transmissions were unsuccessful. The median time
patients had symptoms of palpitations at presentation from ECG transmission to being read by a technician
(20 [24%] patients < 1 min, 21 [25%] patients 1–5 min, was 18 (range 0–3,511) minutes. Of the 424 successful
31 [37%] patients 6 min–1 hr, 11 [13%] patients > 1 hr transmissions, 19 (4%) were unreadable recordings.
in duration). 24 patients had presyncope (eight patients Normal sinus rhythm was diagnosed in 63 patients,
each for < 1 min and 6 min–1 hr, seven patients for 1–6 sinus arrhythmia in 18, sinus tachycardia in nine,
min, one patient for > 1 hr in duration). Three patients premature ventricular contractions in ten, atrial
had previous syncopal episodes. 21 patients had a premature beats in three, sinus bradycardia in one, AF
history of arrhythmia or structural heart disease. Six had in two (2%) and normal paced rhythm in three (3%)
a history of AF. Of these, one patient had a previous AF patients. A comparison between the physician diagnosis
ablation, while another had a previous surgical Maze and computer-generated diagnosis was also made. Of
procedure. Three patients had previous documented the 424 transmissions, a consistent diagnosis was made
SVT. Two patients had previous atrial ectopics by both the reporting physician and the computer-
documented, while another two had ventricular ectopics. generated report in 313 (74%) cases.
One patient had both atrial and ventricular ectopics The percentage of patients successfully diagnosed
Singapore Med J 2010; 51(7) : 568
as a function of time was calculated for both devices.
The TT device yielded 0.55 ± 0.71 diagnoses/patient/
week in Week 1 and 0.58 ± 0.75 diagnoses/patient/week
in Week 2. For HW, 0.62 ± 0.77 diagnoses/patient/week
were made in Week 1 and 0.34 ± 0.55 diagnoses/patient/
week in Week 2. There was a trend toward significance
for Week 2 between TT and HW (p = 0.066) but not
for Week 1 (p = 0.6253). The cumulative percentage of
patients with one, two or three diagnoses as a function
of time was also calculated. At the end of two weeks,
66.7% of patients in TT vs. 67.8% of those in the HW Fig. 2 Kaplan-Meier curves showing the cumulative diagnostic
yield of transtelephonic and HeatWave500 device for patients
group had one or more diagnoses made (Fig. 2).
with one, two or three diagnoses as a function of duration of
monitoring.
DISCUSSION
Compared to a standard Holter, the superiority of patient-
activated TT devices in terms of efficacy and cost- this often means that transmitted data is read only on the
effectiveness is well proven. Studies have shown that a following Monday. This would account for the median
monitoring duration of two weeks is the most cost-effective. time of transmission to review of 1,107 minutes in TT,
In a study by Reiffel et al, it was found that 87% of patients compared to 18 minutes for HW. Early diagnosis of
would have an initial transmission corresponding to significant arrhythmias may be potentially significant,
palpitations in the first two weeks.(5) Only an additional as earlier detection of AF, for example, could have
9% yield would be achieved if monitoring was extended suggested the need for anticoagulation therapy. There
to four weeks. This was the basis for the two-week is also added reassurance for the HW user, as there is
monitoring period utilised in this study. immediate feedback.
Two outcomes were used to compare the The potential application of HW in clinical
effectiveness of HW. The cumulative percentage of practice is substantial. The recent Catheter Ablation
patients with one, two or three diagnoses as a function for the Cure of Atrial Fibrillaton Study used a TT
of time was similar between TT and HW (66.7% vs. ECG recorder for patients one month after ablation.(6)
67.8%). However, at the end of Week 2, there was a Routine daily 30-second recordings were conducted for
trend toward significance for the second outcome of three months. This study showed a substantial number
the number of diagnoses/patient/week in favour of HW of asymptomatic AF recurrences, which was consistent
(0.58 ± 0.75 vs. 0.34 ± 0.55, p = 0.066). This suggests with another study by Senatore et al, where up to 50%
that a monitoring duration of two weeks may not be of AF recurrences were asymptomatic.(7) A device
necessary for HW (with only an additional 0.34 ± 0.55 like HW that can transmit consistently, for prolonged
diagnoses/patient made in Week 2). There are several periods of time and in multiple leads would be superior
possible explanations for this outcome. First, there in detecting AF in this setting. HW can also be used
is feedback on the recorded data via a liquid crystal in patients with chronic heart disease who work out in
display (LCD screen on HW), thus allowing patients public gymnasiums. In a study by Kouidi et al, TT was
to re-record, should the signals be sub-optimal. For used as a monitoring tool for this subset of high-risk
TT, the converted audio signals have to contend with patients and was shown to be safe and efficacious.(8) A
inherent noise levels on fixed telephone lines (our device like HW that gives immediate feedback on a large
current TT devices do not support data transmission LCD screen, a readily available computer-generated
via the global system for mobile communications). diagnosis and immediate SMS warning system would
Consequently, up to 18% of transmitted data from TT be superior to TT. In our study, only three patients in
is unreadable compared to 4% for HW. Better quality the HW group had a permanent pacemaker implanted.
data in multiple channels in HW means that fewer Although a normal paced rhythm was detected for all
transmissions are required before a diagnosis is made, three patients, the usefulness of HW in this setting
thereby cutting down on the monitoring time. Also, remains to be examined.
transmissions are read on the next working day for TT. However, there are practical drawbacks to the HW.
Unlike the HW server, there is no SMS service in TT It records five leads, which would take considerable
when an abnormal rhythm is detected. On a weekend, time and effort to put on. Furthermore, due to its
)%(
stneitaP
100 Transtelephonic HeartWave 500
90
80
70
60
50
40
30
20
10
0
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
No. of days
Singapore Med J 2010; 51(7) : 569
multiple functions, the current model uses more energy. REFERENCES
In the two-week monitoring period, patients often had 1. DiMarco JP, Philbrick JT. Use of ambulatory electrocardiographic
to change batteries at least once, thus increasing the (Holter) monitoring. Ann Intern Med 1990; 113:53-68.
cost. The use of the internet as a transmitting medium 2. Safe AF, Maxwell RT. Transtelephonic electrocardiographic
monitoring for detection and treatment of cardiac arrhythmia.
also has its drawbacks, especially if patients are not
Postgrad Med J 1990; 66:110-2.
computer savvy. The current computer-generated
3. Thomas LE, Shapiro LM, Perrins EJ, Fox KM. Detection of
report software only has 74% consistency with a
arrhythmia: limited usefulness of patient activated recording
physician-read diagnosis.
devices. Br Med J (Clin Res Ed) 1984; 289:1106-7.
In conclusion, HW is an exciting new device
4. Klootwijk P, Leenders CM, Roelandt J. Usefulness of
that offers a glimpse of what future cardiac monitors
transtelephonic documentation of the electrocardiogram during
would look like. It incorporates an essential and
sporadic symptoms suggestive of cardiac arrhythmias. Int J
everyday medium in our lives: the internet. With Cardiol 1986; 13:155-61.
advancing wireless and battery technology, many of 5. Reiffel JA, Schulhof E, Joseph B, et al. Optimum duration
its drawbacks are not insurmountable. In fact, the next of transtelephonic ECG monitoring when used for transient
generation of HW devices is already on the drawing symptomatic event detection. J Electrocardiol 1991; 24:165-8.
board. 6. Stabile G, Bertaglia E, Senatore G, et al. Catheter ablation
treatment in patients with drug-refractory atrial fibrillation: a
ACKNOWLEDGEMENTS prospective, multi-centre, randomized, controlled study (Catheter
Ablation for the Cure of Atrial Fibrillation Study). Eur Heart J
This work was supported by funding from the
2006; 27:216-21.
Enterprise Challenge. The authors would like to
7. Senatore G, Stabile G, Bertaglia E, et al. Role of transtelephonic
acknowledge the National Heart Centre, Singapore
electrocardiographic monitoring in detecting short-term
and all laboratory technicians who have participated in
arrhythmia recurrences after radiofrequency ablation in patients
this trial. The authors would also like to acknowledge
with atrial fibrillation. J Am Coll Cardiol 2005; 45:873-6.
NextWave Biomedical Pte Ltd and Mr Damien Lim,
8. Kouidi E, Farmakiotis A, Kouidis N, Deligiannis A.
Director of Sales and Marketing for their tireless Transtelephonic electrocardiographic monitoring of an outpatient
support and encouragement. cardiac rehabilitation programme. Clin Rehabil 2006; 20:1100-4.
